UAB enrolls nation’s first patient in Phase III drug trial for preeclampsiaIf successful, the drug would be a significant clinical breakthrough for reducing pre-term births and infant mortality.Friedman committed to improving therapies for children with brain cancer
Gregory Friedman, M.D., is working to combat medulloblastoma — the most common malignant pediatric brain tumor — using genetically altered viruses that kill cancer cells and leave normal cells untouched.New approach for HPV screening can be effective in developing countriesThe first HPV and cytology study conducted in rural Nepal suggests self-collected samples may offer effective screening for the deadly infection.No evidence eating fruits and vegetables promotes weight-loss
Eating more fruits and vegetables is good for a number of reasons, but weight-loss isn’t necessarily one of them, UAB researchers say.Simulator to help children learn to cross streets safelyProfessor David Schwebel, Ph.D., developed a new virtual-reality system to help reduce pedestrian injuries and deaths among children.Discovery of how brain tumor cells move points to possible therapyResearch that sheds light on the way gliomas migrate and cause brain tumors may reveal a new avenue to kill them. The findings, published June 19 in Nature Communications, show that gliomas disrupt normal neural connections and hijack control of blood vessels — which may open the door for chemotherapy.Informatics Institute will bridge big data and biomedical researchA new initiative in the School of Medicine will deliver the data to help drive research and advance discoveries.Gender differences emerging in obesity-related mortalityMedical advances and interventions may have helped reduce the effects of obesity on lifespan, especially for women, says findings published in Obesity Reviews.UAB, HudsonAlpha create joint Center for Genomic MedicineThe partnership combines genomics expertise with leadership in research and clinical medicine to speed efforts to deliver personalized therapies and cures.LRRK2 inhibitors may be key to combating Parkinson’s diseaseNew drugs to slow or even prevent Parkinson’s could be in human studies as early as 2015.
- Action Link READ THE ABSTRACT